Patents/Assignees

Aclaris Therapeutics, Inc.

10 patents in portfolio

US12616696utility2026
Crystalline Forms of (p)-3-chloro-4-((3,5-difluoropyridin-2-yl)methoxy)-2′-(2-(2-hydroxypropan-2-yl)pyrimidin-4-yl)-5′,6-dimethyl-2h-[1,4′-bipyridin]-2-one
0 cites
US12403141utility2025
Deuterated MK2 Pathway Inhibitors and Methods of Using the Same
0 cites
US12384757utility2025
Methods of Synthesizing Substituted Pyridinone-pyridinyl Compounds
0 cites
US12370195utility2025
Oral Compositions of MK2 Pathway Inhibitor for Treatment of Immune Conditions
0 cites
US12297203utility2025
Pyrrolopyrimidine ITK Inhibitors
0 cites
US12281111utility2025
Substituted Pyrrolopyridine JAK Inhibitors and Methods of Making and Using the Same
0 cites
US11844801utility2023
Oral Compositions of MK2 Pathway Inhibitor for Treatment of Immune Conditions
0 cites
US11820775utility2023
Pyrrolopyrimidine ITK Inhibitors
0 cites
US11767309utility2023
Methods of Synthesizing Substituted Pyridinone-pyridinyl Compounds
0 cites
US11739086utility2023
Substituted Pyrrolopyridine JAK Inhibitors and Methods of Making and Using the Same
0 cites